New biomarker strategies to enable precision cardiovascular medicine.

Main|Search|PHGKB




Last Posted: Jul 19, 2018

---

• New biomarker strategies to enable precision cardiovascular medicine.  
  Bede Kristen et al. Current opinion in cardiology 2018 Jul
• Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy  
  RD Bagnall et al, JACC, July 2018
• Whole Genome Sequencing in Hypertrophic Cardiomyopathy  
  American College Cardiology, July 17, 2018
• [Modern genetic counselling : Practical aspects exemplified by hypertrophic cardiomyopathy].  
  Czepluch F et al. Der Internist 2018 Jun
• [Genetic tests in hypertrophic cardiomyopathy: Benefits, limitations, and applications in clinical practice].  
  Gómez Arraiz I et al. Semergen 2018 May
• Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center.  
  Mazzarotto Francesco et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 Jun
• Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center  
  F. Mazzaratto et al, Genetics in Medicine, June 6, 2018
• Diagnostic Yield of Genetic Testing in Young Athletes with T-wave Inversion.  
  Sheikh Nabeel et al. Circulation 2018 May
• NGS testing for cardiomyopathy: Utility of adding RASopathy-associated genes.  
  Ceyhan-Birsoy Ozge et al. Human mutation 2018 Apr
• Association of Cardiomyopathy With MYBPC3 D389V and MYBPC3Δ25bpIntronic Deletion in South Asian Descendants.  
  Viswanathan Shiv Kumar et al. JAMA cardiology 2018 Apr

more